Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05293340 · ClinicalTrials.gov registry record · NA
Continuous Glucose Monitoring and Hass Avocado Trial ("CHAT")
A NA study, sponsored by Sansum Diabetes Research Institute.
- Terminated
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT05293340 is a NA study that was terminated before completion, run by Sansum Diabetes Research Institute. The registered enrollment target is 50 participants.
The verdict
NCT05293340, a NA study, was terminated before completion, sponsored by Sansum Diabetes Research Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Hispanic/Latino adults in the United States (U.S.) bear a disproportionate burden of type 2 diabetes (T2D). Dietary changes, facilitated by increased access and adherence to healthy foods, are necessary. In this study, continuous glucose monitoring (CGM) will be used to quantify changes in glycemic control in Hispanic/Latino (predominantly of Mexican origin) adults with or at-risk of T2D before and after receiving free avocados for 12 weeks. Beyond CGM-measured glycemic control, wearable activity and sleep monitors, physical exams, laboratory analyses, and questionnaires/logs will be used to track the impact of free avocado vouchers. The findings are anticipated to help clinicians provide new information to support positive behavior change to reduce the risk of T2D or progression from pre-diabetes to T2D and make it easier for patients to access healthier food, potentially leading to improved health.
Interventions
- DIETARY_SUPPLEMENT Avocado Vouchers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-03-31 |
| Est. Completion | 2023-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05293340
The ClinicalTrials.gov registry entry for NCT05293340 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sansum Diabetes Research Institute, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Avocado Vouchers is the first listed.
NCT05293340 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05293340 about?
NCT05293340 is a clinical study titled "Continuous Glucose Monitoring and Hass Avocado Trial ("CHAT")". Hispanic/Latino adults in the United States (U.S.) bear a disproportionate burden of type 2 diabetes (T2D). Dietary changes, facilitated by increased access and adherence to healthy foods, are necessary. In this study, continuous glucose monitoring (CGM) will be used to quantify changes in glycemic ...
What is the current status of trial NCT05293340?
This trial is currently terminated. It is a NA study. The enrollment target is 50 participants. The study started on 2022-03-31. Estimated completion is 2023-01-31.
What interventions are being tested in trial NCT05293340?
The interventions under investigation include: Avocado Vouchers (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05293340?
This trial is sponsored by Sansum Diabetes Research Institute, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.